title: Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Clavarezza
authors.forename: Lucia
authors.initials: L
authors.lastname: Del Mastro
authors.forename: Paolo
authors.initials: P
authors.lastname: Pronzato
authors.forename: Paolo
authors.initials: P
authors.lastname: Bruzzi
authors.forename: Marco
authors.initials: M
authors.lastname: Venturini
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000453:epidemiology; D006278:Medicare; D009190:Myelodysplastic Syndromes / Q000139:chemically induced* / Q000453:epidemiology; D018426:SEER Program; D012680:Sensitivity and Specificity; D014481:United States
chemical_list: D016178:Granulocyte-Macrophage Colony-Stimulating Factor